SARS-CoV-2 Mpro-IN-49
SARS-CoV-2 Mpro-IN-49 (Compound 22e) is a potent SARS-CoV-2 main protease (Mpro) inhibitor (IC50=0.087 μM) . SARS-CoV-2 Mpro-IN-49 is promising for research of SARS-CoV-2 and coronavirus[1].
Product Specifications
UNSPSC
12352005
Target
SARS-CoV; Virus Protease
Related Pathways
Anti-infection
Field of Research
Infection
Smiles
COC1=CC=C(C2=CC(Cl)=C(C(N3[C@H](C(N[C@@H](C[C@H]4C(NCC4)=O)C#N)=O)[C@@](C5(C)C)([H])[C@@]5([H])C3)=O)C=C2)C=C1
Molecular Formula
C29H31ClN4O4
Molecular Weight
535.03
References & Citations
[1]Clyde-Allen E, et al. Identification and Exploration of a Series of SARS-Cov‑2 MPro Cyano-Based Inhibitors Revealing Ortho-Substitution Effects within the P3 Biphenyl Group. ACS Med Chem Lett. 2025 Sep 25;16 (10) :1935-1945.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS9924935 Inquire
Cavy T-Cell Receptor Beta Chain V Region YT35 (TRBV12-3) ELISA Kit
Ask
View Details 
I8441-01A-01 2 µg
Interleukin 19, Recombinant, Human (IL-19, Melanoma Differentiation Associated like Protein) discontinued
Ask
View Details I8441-01A-02 10 µg
Interleukin 19, Recombinant, Human (IL-19, Melanoma Differentiation Associated like Protein) discontinued
Ask
View Details